| Autor: |
Stanczak MA; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Rodrigues Mantuano N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Kirchhammer N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Sanin DE; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Jacob F; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Coelho R; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Everest-Dass AV; Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast QLD4222, Australia., Wang J; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Trefny MP; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Monaco G; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Bärenwaldt A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Gray MA; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA., Petrone A; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Kashyap AS; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Glatz K; Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland., Kasenda B; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland., Normington K; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Broderick J; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Peng L; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Pearce OMT; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University, London EC1M 6BQ, UK., Pearce EL; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Bertozzi CR; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA., Zippelius A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland., Läubli H; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland. |
